Literature DB >> 15151986

alphavbeta3 integrin-dependent endothelial cell dynamics in vivo.

Paul A Rupp1, András Czirók, Charles D Little.   

Abstract

A major challenge confronting developmental cell biologists is to understand how individual cell behaviors lead to global tissue organization. Taking advantage of an endothelial cell-specific marker and scanning time-lapse microscopy, we have examined the formation of the primary vascular pattern during avian vasculogenesis. Five types of distinguishable endothelial cell motion are observed during formation of a vascular plexus: (1) global tissue deformations that passively convect endothelial cells; (2) vascular drift, a sheet-like medial translocation of the entire vascular plexus; (3) structural rearrangements, such as vascular fusion; (4) individual cell migration along existing endothelial structures; and (5) cell process extension into avascular areas, resulting in new links within the plexus. The last four types of motion are quantified and found to be reduced in the presence of an alphavbeta3 integrin inhibitor. These dynamic cell motility data result in new hypotheses regarding primordial endothelial cell behavior during embryonic vasculogenesis.

Mesh:

Substances:

Year:  2004        PMID: 15151986     DOI: 10.1242/dev.01160

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  25 in total

1.  A steering model of endothelial sheet migration recapitulates monolayer integrity and directed collective migration.

Authors:  Philip Vitorino; Mark Hammer; Jongmin Kim; Tobias Meyer
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

2.  In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD.

Authors:  Lucie Sancey; Valérie Ardisson; Laurent M Riou; Mitra Ahmadi; Danièle Marti-Batlle; Didier Boturyn; Pascal Dumy; Daniel Fagret; Catherine Ghezzi; Jean-Philippe Vuillez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-04       Impact factor: 9.236

3.  Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling.

Authors:  Roeland M H Merks; Sergey V Brodsky; Michael S Goligorksy; Stuart A Newman; James A Glazier
Journal:  Dev Biol       Date:  2005-12-01       Impact factor: 3.582

4.  Vascular sprout formation entails tissue deformations and VE-cadherin-dependent cell-autonomous motility.

Authors:  Erica D Perryn; András Czirók; Charles D Little
Journal:  Dev Biol       Date:  2007-11-04       Impact factor: 3.582

Review 5.  Multicellular sprouting during vasculogenesis.

Authors:  Andras Czirok; Evan A Zamir; Andras Szabo; Charles D Little
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

6.  Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study.

Authors:  Paul A Rupp; Richard P Visconti; András Czirók; David A Cheresh; Charles D Little
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

7.  Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate.

Authors:  Amit K Jha; Anurag Mathur; Felicia L Svedlund; Jianqin Ye; Yerem Yeghiazarians; Kevin E Healy
Journal:  J Control Release       Date:  2015-04-27       Impact factor: 9.776

8.  Multicellular sprouting in vitro.

Authors:  Andras Szabo; Elod Mehes; Edina Kosa; Andras Czirok
Journal:  Biophys J       Date:  2008-06-20       Impact factor: 4.033

Review 9.  Extracellular matrix dynamics in tubulogenesis.

Authors:  Rajprasad Loganathan; Charles D Little; Brenda J Rongish
Journal:  Cell Signal       Date:  2020-04-02       Impact factor: 4.315

10.  Dynamic analysis of vascular morphogenesis using transgenic quail embryos.

Authors:  Yuki Sato; Greg Poynter; David Huss; Michael B Filla; Andras Czirok; Brenda J Rongish; Charles D Little; Scott E Fraser; Rusty Lansford
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.